Agile Talent author Jon Younger looks at trends driving—and emerging from—the freelance talent revolution.
Get our free guide to working with on-demand talent.
Read Now
Agile Talent author Jon Younger looks at trends driving—and emerging from—the freelance talent revolution.
Get our free guide to working with on-demand talent.
Read NowThe product development and launch cycle within pharmaceuticals, biotech, and medical devices has long made these industries a perfect fit for on-demand talent.
Corporate and business development leaders are seeking independent talent with the expertise to help them navigate rapid consolidation and evolving market dynamics.
The data management and governance team within the neuroscience unit at an F500 pharma company was looking for a senior business analyst to support the re-architecture of various data feeds within...
A large pharma company with several novel assets in the pipeline sought external support assessing digital efforts to date and creating a roadmap for digital technology investments to maximize the...
The Rare Disease HCP marketing team at a F200 biopharma company was preparing for a significant product launch during the COVID-19 pandemic and required a strong, execution-oriented project...
A large pharma company was considering changes to the business’ diabetes sales strategy in the US, including shifting sales representatives dedicated to insulin products to other products within...
An F500 pharma company required therapeutic area strategy support determining how to go to market in the obesity space and support several molecules under development. Business Talent Group (BTG)...
The Omnichannel Marketing Director at an F100 pharma company needed support with the development and launch of a new omnichannel patient marketing campaign for a major depressive disorder...
An F1000 pharmaceutical company had fallen behind schedule on introducing their oncology drug to market and needed external support to develop and accelerate a launch strategy. Business Talent...
A major pharmaceutical company was pursuing an agile launch strategy for a new rare disease therapy, requiring a high level of coordination within the organization. Seeking assistance with...
Access the life sciences commercial talent you need to work smarter, faster, and more flexibly across all marketing, sales, innovation, and analytics initiatives.
Succeeding in today’s commercial environment requires agility and rapid response to new market conditions and quickly evolving consumer attitudes and behaviors. Here's how independent talent can help.
A Fortune 200 pharmaceutical company needed to develop a resource plan for the launch of a rare disease product with an upcoming phase III readout. To align stakeholders, the VP, Commercial for...
To enable its transformation into a best-in-class omnichannel organization, the Omnichannel Customer Engagement & Digital Operations (OCE&DO) team at one of Europe’s largest pharmaceutical...
An F200 biotechnology company identified an opportunity to enhance and build capabilities in commercial marketing. For support, the Commercial Transformation Project Lead contacted BTG to bring in...
A large biotechnology company was seeking to standardize branding and operations across multiple established products to achieve greater consistency and operational efficiencies. In need of a...
47:32In this on-demand webinar, we speak with Steve Wunker—Managing Director of New Markets Advisors—about how costovation enables companies to meet, and even exceed, customers’ expectations, cheaply
Data-driven insights are key to flourish in the post-pandemic economy, but it can be challenging to find resources to harness those insights effectively.
A multinational pharma company was seeking to launch a healthcare provider (HCP) locator solution that would help patients identify a doctor for treatment. They needed support in mapping and...
Digital health has grown and evolved rapidly in the past decade—spurred by exciting developments in AI, machine learning, and the internet of things (IoT), alongside nearly ubiquitous adoption of smar